Parallel Multi-Omics in High-Risk Subjects for the Identification of Integrated Biomarker Signatures of Type 1 Diabetes

Abstract

Background: Biomarkers are crucial for detecting early type-1 diabetes (T1D) and preventing significant β-cell loss before the onset of clinical symptoms. Here, we present proof-of-concept studies to demonstrate the potential for identifying integrated biomarker signature(s) of T1D using parallel multi-omics. Methods: Blood from human subjects at high risk for T1D (and healthy controls; n = 4 + 4) was subjected to parallel unlabeled proteomics, metabolomics, lipidomics, and transcriptomics. The integrated dataset was analyzed using Ingenuity Pathway Analysis (IPA) software for disturbances in the at-risk subjects compared to controls. Results: The final quadra-omics dataset contained 2292 proteins, 328 miRNAs, 75 metabolites, and 41 lipids that were detected in all samples without exception. Disease/function enrichment analyses consistently indicated increased activation, proliferation, and migration of CD4 T-lymphocytes and macrophages. Integrated molecular network predictions highlighted central involvement and activation of NF-κB, TGF-β, VEGF, arachidonic acid, and arginase, and inhibition of miRNA Let-7a-5p. IPA-predicted candidate biomarkers were used to construct a putative integrated signature containing several miRNAs and metabolite/lipid features in the at-risk subjects. Conclusions: Preliminary parallel quadra-omics provided a comprehensive picture of disturbances in high-risk T1D subjects and highlighted the potential for identifying associated integrated biomarker signatures. With further development and validation in larger cohorts, parallel multi-omics could ultimately facilitate the classification of T1D progressors from non-progressors.

Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages

“…However, few studies are focused on lipidomic and miRNAs integration, which allow us to identify different biological activities involved in cell communication [ 27 ]. In general, the integration of omics results (lipidomics, metabolomics, proteomics, epigenomics) helps to give a global image of the mechanisms involved in complex diseases [ 28 ]. Nevertheless, this field of research is still underdeveloped in AD and few studies are based on this integration [ 16 ].…”

Multi-omics Characterization of Neutrophil Extracellular Trap Formation in Severe and Mild COVID-19 Infections

“…Major plasma proteins were immunodepleted using a Multiple Affinity Removal System (MARS) column (Hu-14 4.6 x 100 mm, Agilent Technologies, Santa Clara, CA) column in-line with an Agilent 1200 HPLC system and analyzed as described previously (67). Flow-through fractions were collected and concentrated from the depletion column as described previously (57).…”

Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema

“…More recently, the upregulation of arginase, an enzyme that catalyzes L-ornithine and urea from L-arginine, has been linked to oxidative stress and peripheral vascular dysfunction in diabetes [ 24 , 25 , 26 ]. Another recent work utilizing a quadra-omics approach (proteomics, lipidomics, metabolomics, and transcriptomics) examined blood samples from patients with Type 1 DM and discovered the activation of TGF-β, VEGF, NF-κB, and arginase with the inhibition of miRNA Let-7a-5p [ 27 ]. These pathways and mediators are thought to incite oxidative stress by overproducing reactive oxygen species, causing defects in angiogenesis, and activating pro-inflammatory pathways.…”